Effect of treatment with epoprostenol and endothelin receptor antagonists on the development of thyrotoxicosis in patients with pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Effect of treatment with epoprostenol and endothelin receptor antagonists on the development of thyrotoxicosis in patients with pulmonary arterial hypertension

Published:2017 Issue:12 Volume:64 Page:1173-1180
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Satoh Mari¹,Aso Keiko¹,Nakayama Tomotaka¹,Saji Tsutomu²

Affiliation:

1. Department of Pediatrics, Toho University Omori Medical Center, Tokyo 143-8541, Japan

2. Advanced and Integrated Cardiovascular Research Course in the Young and Adolescence, Toho University, Tokyo 143-8540, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/64/12/64_EJ17-0155/_pdf

Reference28 articles.

1. 1. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, et al. (2013) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62: D34-41.

2. 2. Elliott CG (2013) Genetics of pulmonary arterial hypertension. Clin Chest Med 34: 651-663.

3. 3. Chu JW, Kao PN, Faul JL, Doyle RL (2002) High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension. Chest 122: 1668-1673.

4. 4. Castillo Palma MJ, García Herández FJ, Montero Benavides P, González León R, Ocaña Medina C, et al. (2009) Thyroid dysfunction in patients with pulmonary arterial hypertension. A cohort study of 58 patients. Med Clin (Barc) 132: 695-700 (In Spanish).

5. 5. Chadha C, Pritzker M, Mariash CN (2009) Effect of epoprostenol on the thyroid gland: enlargement and secretion of thyroid hormone. Endocr Pract 15: 116-121.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Giant Goiter Associated with Airway Stenosis Caused by Long-Term Intravenous Epoprostenol Therapy for Idiopathic Pulmonary Arterial Hypertension;Journal of Clinical Medicine;2023-10-04

2. Pancreatic enlargement in a patient receiving therapy with vasodilators for pulmonary arterial hypertension: a case report;Abdominal Radiology;2022-03-07

3. Experience with Selexipag to Treat Pulmonary Arterial Hypertension;Kardiologiia;2020-05-04

4. Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol;Case Reports in Pulmonology;2020-01-23

5. Thyroid Dysfunction in Patients with Pulmonary Artery Hypertension (PAH): The Effect of Therapies Affecting the Prostanoid Pathway;Lung;2019-11-06